Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Historically, the FDA has strongly warned against the use of peptides not approved for marketing due to a lack of data from clinical human trials, the risks of allergic reactions and unknown manufacturing impurities, particularly when compounded
Strongest Current Evidence CagriSema REDEFINE 1 and REDEFINE 2 are completed phase 3 trials published in NEJM with over 4,600 participants
FeelGood's $149/month entry price is in the lower range of the publicly advertised compounded GLP-1 telehealth market
Visible results typically appear after 3-5 sessions
Mechanism of Action: How Ipamorelin Releases GH Ipamorelin binds to the GHS-R1a receptor on anterior pituitary somatotroph cells
doi: 10.1111/acel.12219 90 HoongCWSChuaMWJ
US$ 22.05
US$ 28.09
US$ 25.05
US$ 24.85
